Patient perspectives central for developing new therapies for COPD
Miami (December 4, 2024) – The perspectives and priorities of people living with chronic obstructive pulmonary disease (COPD) should be integrated into the development process of new therapies for COPD, according to a new commentary. The article is published in the Annals of the American Thoracic Society.
COPD comprises several conditions, including chronic bronchitis and emphysema, and can be caused by genetics and irritants like smoke or pollution. The disease affects more than 15 million Americans and is the fourth leading cause of death worldwide, yet awareness of the disease’s symptoms, methods to reduce risk, and disease management remains ...







